Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
We describe four patients from two unrelated families of different ethnicities with a primary immunodeficiency, predominantly manifesting as susceptibility to EBV-related diseases. Three patients presented with EBV-associated Hodgkin?s lymphoma and hypogammaglobulinemia; one also had severe varicella infection. The fourth had viral encephalitis during infancy. Homozygous frameshift or in-frame deletions in CD70 in these patients abolished either CD70 surface expression or binding to its cognate receptor CD27. Blood lymphocyte numbers were normal, but the proportions of memory B cells and EBV-specific effector memory CD8+ T cells were reduced. Furthermore, although T cell proliferation was normal, in vitro-generated EBV-specific cytotoxic T cell activity was reduced due to CD70 deficiency. This reflected impaired activation by, rather than effects during killing of, EBV-transformed B cells. Notably, expression of 2B4 and NKG2D - receptors implicated in controlling EBV infection - on memory CD8+ T cells from CD70-deficient individuals was reduced, consistent with their impaired killing of EBV-infected cells. Thus, autosomal recessive CD70 deficiency is a novel cause of combined immunodeficiency and EBV-associated diseases, reminiscent of inherited CD27 deficiency. Overall, human CD70-CD27 interactions therefore play a non-redundant role in T- and B-cell mediated immunity, especially for protection against EBV and humoral immunity.
|Authors||Abolhassani, H.; Edwards E.; Ikinciogullari, A.; Jing, H.; Borte, S.; Buggert, M.; Du, L.; Matsuda-Lennikov,M.; Romano, R.; Caridha, R.; Bade, S.; Zhang, Y.; Frederiksen, J.; Fang, M.; Kostel Bal, S.; Haskologlu, S.; Dogu, F.; Tacyildiz, N.; Matthews, HF.; McElwee, JJ.; Gostick, E.; Price, DA.; Palendira, U.; Aghamohammadi, A.; Boisson, B.; Rezaei, N.; Karlsson, AC.; Lenardo, MJ.; Casanova, JL.; Hammarstrom, L.; Tangye, SG.; Su, HC.; Pan-Hammarstrom, P.|
|Responsible Garvan Author|
|Publisher Name||J EXP MED|
|Published Date||2017-01-01 00:00:00|